[Serum beta 2-microglobulin and HLA alloantigens in primary Gougerot-Sjögren syndrome. A possible relation with HLA-DR3 specificity].
The relationships between some allo-antigens of the HLA system and beta 2-microglobulin (beta 2m) serum level were examined in a group of 24 subjects with primitive Sjögren's syndrome (pSS). While the beta 2m serum level of all the patients with pSS were higher at the limits of significance (p congruent to 0.05), compared to the values of the 14 control subjects, the division of the patients into two sub-groups of 14 and 10 subjects, according to the presence or absence of the haplotypes DR2 and/or DR3, pointed up a beta 2m serum level which was significantly higher in the first compared to the second (p less than 0.02) and to the group of normal subjects (p less than 0.01). Among the individual haplotypes studied, only the DR3 was observed with a significantly greater frequency (p less than 0.01) in the patients compared to the control group. The haplotype DR3 and also the B8, although at a lesser level, were found to be correlated with a high value of the serum beta 2m: p less than 0.004 and p less than 0.05 respectively. A similar association was not found for the DR2 and DRW52 specificities.
Bianucci
G
G
I'stituto di Clinica Medica I, Servizio di Medicina Nucleare USL, Firenze, Italie.
Campana
G
G
Maddali-Bongi
S
S
D'Agata
A
A
Pradella
F
F
Colafranceschi
M
M
Castagnoli
A
A
D000328:Adult; D000368:Aged; D000939:Epitopes / Q000032:analysis; D005260:Female; D006680:HLA Antigens / Q000032:analysis*; D015803:HLA-DR3 Antigen / Q000032:analysis; D006801:Humans; D007519:Isoantigens / Q000032:analysis*; D008875:Middle Aged; D012859:Sjogren's Syndrome / Q000097:blood / Q000276:immunology*; D001613:beta 2-Microglobulin / Q000032:analysis*
D000939:Epitopes; D006680:HLA Antigens; D015803:HLA-DR3 Antigen; D007519:Isoantigens; D001613:beta 2-Microglobulin
La beta 2-microglobulinémie sérique et les allo-antigènes du système HLA au cours du syndrome de Gougerot-Sjögren primitif. Une relation possible avec la spécificité HLA-DR3.